These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 30338790

  • 1. MicroRNA-373-3p inhibits prostate cancer progression by targeting AKT1.
    Qu HW, Jin Y, Cui ZL, Jin XB.
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6252-6259. PubMed ID: 30338790
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-520d-3p inhibits osteosarcoma progression by degradation of Akt1.
    He TD, Zhu JK, Wei ZX, Wang YM.
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2315-2320. PubMed ID: 29762834
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-556-3p promotes the progression of esophageal cancer via targeting DAB2IP.
    Lu HB.
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6816-6823. PubMed ID: 30402845
    [Abstract] [Full Text] [Related]

  • 4. MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4.
    Hu CY, You P, Zhang J, Zhang H, Jiang N.
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5133-5138. PubMed ID: 31298366
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2.
    Zhou YJ, Yang HQ, Xia W, Cui L, Xu RF, Lu H, Xue Z, Zhang B, Tian ZN, Cao YJ, Xing ZY, Yin S, He XZ.
    Life Sci; 2017 Dec 01; 190():7-14. PubMed ID: 28943214
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-1236-3p inhibits proliferation and invasion of breast cancer cells by targeting ZEB1.
    Liang TC, Fu WG, Zhong YS.
    Eur Rev Med Pharmacol Sci; 2019 Nov 01; 23(22):9988-9995. PubMed ID: 31799668
    [Abstract] [Full Text] [Related]

  • 7. microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.
    Li Y, He S, Zhan Y, He A, Gong Y, Ji G, Huang C, Peng D, Guan B, Li X, Zhou L.
    DNA Cell Biol; 2019 Aug 01; 38(8):840-848. PubMed ID: 31314587
    [Abstract] [Full Text] [Related]

  • 8. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ, Song YL, Gao F.
    Eur Rev Med Pharmacol Sci; 2019 Oct 01; 23(20):8795-8805. PubMed ID: 31696466
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
    Chen H, Luo Q, Li H.
    Tumour Biol; 2017 Mar 01; 39(3):1010428317695941. PubMed ID: 28345464
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-199b-3p suppresses malignant proliferation by targeting Phospholipase Cε and correlated with poor prognosis in prostate cancer.
    Liu J, Quan Z, Gao Y, Wu X, Zheng Y.
    Biochem Biophys Res Commun; 2021 Oct 22; 576():73-79. PubMed ID: 34482026
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-373-3p inhibits the growth of cervical cancer by targeting AKT1 both in vitro and in vivo.
    Yu MM, Wang GJ, Wu KH, Xue SL, Ju LL, Li QR, Xiong AW, Yin GP.
    Acta Biochim Pol; 2021 Jul 08; 68(4):611-617. PubMed ID: 34236826
    [Abstract] [Full Text] [Related]

  • 12. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
    Yu XY, Tian JR, Yang D, Tan HR.
    Eur Rev Med Pharmacol Sci; 2019 Jun 08; 23(12):5293-5300. PubMed ID: 31298381
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-212 participates in the development of prostate cancer by upregulating BMI1 via NF-κB pathway.
    Qu HW, Jin Y, Cui ZL, Jin XB.
    Eur Rev Med Pharmacol Sci; 2018 Jun 08; 22(11):3348-3356. PubMed ID: 29917185
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-140 inhibits proliferation and promotes apoptosis and cell cycle arrest of prostate cancer via degrading SOX4.
    Liu Y, Li F, Lai D, Xie Q, Yin Y, Yang M, Su Z.
    J BUON; 2019 Jun 08; 24(1):249-255. PubMed ID: 30941977
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-217 alleviates development of non-small cell lung cancer by inhibiting AKT3 via PI3K pathway.
    Qi YJ, Zha WJ, Zhang W.
    Eur Rev Med Pharmacol Sci; 2018 Sep 08; 22(18):5972-5979. PubMed ID: 30280779
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y, Pan J, Huang S, Peng X, Zou X, Luo Y, Ren D, Zhang X, Li R, He P, Wa Q.
    J Exp Clin Cancer Res; 2018 Jul 18; 37(1):160. PubMed ID: 30021600
    [Abstract] [Full Text] [Related]

  • 17. microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.
    Zhang X, Pan Y, Fu H, Zhang J.
    Med Sci Monit; 2019 Feb 11; 25():1122-1132. PubMed ID: 30741252
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
    Yang B, Liu Z, Ning H, Zhang K, Pan D, Ding K, Huang W, Kang XL, Wang Y, Chen X.
    Cancer Biomark; 2016 Jul 08; 17(2):223-30. PubMed ID: 27434290
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1.
    Zhang X, Jin K, Luo JD, Liu B, Xie LP.
    Neoplasma; 2019 Sep 08; 66(5):704-716. PubMed ID: 31129966
    [Abstract] [Full Text] [Related]

  • 20. miR-454-3p Is an Exosomal Biomarker and Functions as a Tumor Suppressor in Glioma.
    Shao N, Xue L, Wang R, Luo K, Zhi F, Lan Q.
    Mol Cancer Ther; 2019 Feb 08; 18(2):459-469. PubMed ID: 30413650
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.